Health Experts Raise Concerns Over Fda's Approval of Nicotine Pouches

WHO:

CBS News - Health advocates and doctors are raising concerns about nicotine pouches.

NPR - Bret Koplow is the acting director of the FDA's Center for Tobacco Products. Mitch Zeller is a professor at Dartmouth Geisel School of Medicine and former director at the FDA's Center for Tobacco Products. Brian Erkkila is the director of external affairs and head of scientific engagement for Zyn's parent company, Philip Morris International. Bonnie Halpern-Felsher is a professor of pediatrics at Stanford University. Dr. Robert Jackler is a Stanford University professor emeritus. Mary Hrywna is a professor at Rutgers School of Public Health. Emily Hilliard is a senior press secretary for the Department of Health and Human Services.

WHAT:

CBS News - The FDA approved the marketing of nicotine pouches, which some health experts consider a "profound risk" for young people.

NPR - The FDA authorized Zyn to advertise that using it instead of cigarettes puts users at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.

NPR - From 2024 to 2025, lifetime use of nicotine pouches among 12th-graders increased from 6.8% to 10.0%. In 2025, 4.4% of 12th-graders reported using nicotine pouches within the past 30 days.

WHERE:

NPR - The nicotine pouches are marketed in the United States.

WHEN:

NPR - The FDA's 2025 authorization credited flavors with helping adult smokers switch to nicotine pouches.

WHY:

NPR - The FDA's decision is intended to provide adult users with clear, science-based information about the relative harms of tobacco products.

NPR - Advocates of nicotine pouches argue they are a safer alternative to cigarettes and can help reduce the 480,000 or more U.S. deaths attributable to tobacco each year.

HOW:

NPR - Nicotine pouches are used by placing a small pouch filled with nicotine crystals between the lip and gum, allowing nicotine to leach into the bloodstream.

NPR - Zyn's marketing strategy includes flavors like "Cool Mint," "Smooth," and "Chill," and positions the product as a lifestyle enhancer through advertisements featuring active individuals.

(UPDATED August 5, 2026 22:14 UTC)

Health advocates and doctors are expressing serious concerns about nicotine pouches, which the FDA recently approved for marketing, despite warnings that they pose a "profound risk" to young people. The FDA has authorized Zyn to promote its product as a safer alternative to cigarettes, claiming it reduces the risk of various serious health issues, and data shows that lifetime use among 12th-graders rose from 6.8% to 10.0% between 2024 and 2025. Nicotine pouches, marketed in the U.S. with appealing flavors like "Cool Mint" and "Chill," are designed to be used by placing a pouch between the lip and gum, allowing nicotine to enter the bloodstream.